BBC News
Published
image captionJody Lewis says she has a whole future ahead since taking Kaftrio
A woman who has cystic fibrosis (CF) says a new NHS treatment is like regaining six years of her life.
Jody Lewis, 31, is one of around 80 people in Wales to have had Kaftrio, a revolutionary drug treatment, at Liverpool Heart and Chest Hospital.
The treatment is suitable for around 90% of CF patients aged 12 and over and has been approved for use in the UK.
Ms Lewis, who lives in Pen-y-Lan near Wrexham, said since taking it she had a whole future and life ahead of her.
People in Wales will receive the first doses of the Moderna vaccine on Wednesday.
The UK has bought 17 million doses of that vaccine – enough for 8.5 million people.
Jabs will be given out at West Wales General Hospital in Carmarthen in what has been hailed as “another key milestone” in the fight against coronavirus.
Investigations are continuing into any potential association of the Oxford/AstraZeneca jab with a rare form of blood clot (Yui Mok/PA)
It comes as a trial of the Oxford/AstraZeneca vaccine in children has been paused while regulators investigate reports of a rare form of blood clot among adults.
People in Wales will receive the first doses of the Moderna vaccine on Wednesday.
The UK has bought 17 million doses of that vaccine – enough for 8.5 million people.
Jabs will be given out at West Wales General Hospital in Carmarthen in what has been hailed as “another key milestone” in the fight against coronavirus.
Investigations are continuing into any potential association of the Oxford/AstraZeneca jab with a rare form of blood clot (Yui Mok/PA)
It comes as a trial of the Oxford/AstraZeneca vaccine in children has been paused while regulators investigate reports of a rare form of blood clot among adults.
People in Wales will receive the first doses of the Moderna vaccine on Wednesday.
The UK has bought 17 million doses of that vaccine – enough for 8.5 million people.
Jabs will be given out at West Wales General Hospital in Carmarthen in what has been hailed as “another key milestone” in the fight against coronavirus.
Investigations are continuing into any potential association of the Oxford/AstraZeneca jab with a rare form of blood clot (Yui Mok/PA)
It comes as a trial of the Oxford/AstraZeneca vaccine in children has been paused while regulators investigate reports of a rare form of blood clot among adults.